In breast cancer, IL‐10 is involved in the anti‐tumour response via inhibition of gene expression, cytokine synthesis by T cells and macrophages and modulation of their antigen presentation function (Esquivel‐Velázquez et al. 2015). Here, IL10 is linked to breast carcinoma.